ClinicalTrials.gg
RecruitingNCT06602518Updated Sep 19, 2024

Changes in the Sagittal Pharyngeal Airway Dimension Following Leveling and Alignement in Class II Division 2 Patients

An interventional study of Orthodontic Treatment in Class II Division 2 Malocclusion, sponsored by Nourhan M.Aly. Recruiting at 1 site in Egypt. Open to participants aged 12 Years to 16 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Nourhan M.Aly · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Not applicable
Ages
12 Years to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Malocclusion, Angle Class II with a site in Egypt — 6 open to participants now, 6 under way, none of them phase 3. Malocclusion, Angle Class II · Egypt.

Planned enrollment
6th of 25
27 · median 24
Started
2024
the only one that year
No phase
25 of 25
6 open now
Registered
20th of 25
by date

Among the 25 studies in Malocclusion, Angle Class II with a site in Egypt, this one is the 6th largest by planned enrollment, is the only one that started in 2024, is one of 25 with no phase, and was the 20th registered.

Malocclusion, Angle Class II

125 studies on the registry are indexed under Malocclusion, Angle Class II; 19 are open to participants now.

Browse Malocclusion, Angle Class II studies →

Open to participants now

6 of the 25 studies in Malocclusion, Angle Class II with a site in Egypt are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 11 Malocclusion, Angle Class II studies recruiting now, 1 (9%) sets no upper age limit and 10 (91%) stop at 75 or younger; 8 take children under 18; 2 take healthy volunteers.

This study: 12 Years to 16 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Malocclusion, Angle Class II with a site in Egypt, or all of them as a file.
02

Study summary

Aim of the study: is to compare the changes in the sagittal pharyngeal airway dimension (SPAD) and mandibular position before and after the levelling and alignment stage of orthodontic treatment in Class II division 2 patients.

03

Conditions studied

  • Class II Division 2 Malocclusion
04

Who can participate

Ages eligible
12 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Class II/2 subjects as per the British Standard Institute Classification.
  • Age ranging from 12-16 years, with Cervical Vertebral Maturational Index (CVMI) stages 4, and 5.
  • Contact between maxillary and mandibular incisors, with the presence of a deep bite of at least 70%.
  • Full permanent dentition, aside from the third molars

Exclusion criteria

Exclusion Criteria:

  • Previous orthodontic treatment.
  • Patients with severe transverse problems, pain and/or clicking sound in the temporomandibular joint (TMJ).
  • Patients with craniofacial anomalies or diagnosed syndromes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
27 participants (estimated)

Study arms

  • Experimental
    Levelling and alignment

    Procedure: Orthodontic Treatment

Interventions

  • ProcedureOrthodontic Treatment

    All the enrolled patients will undergo conventional fixed appliance therapy by bonding straight wire Roth appliance in the maxillary arch. The bonding procedure will be standardized in all patients and performed by the same operator using light-cured composite. Levelling and alignment will then be started using the following wire sequence: 0.014-in nickel titanium (NiTi), 0.018-in NiTi, 17×25-in Niti, and 19×25-in Niti arch wires. The upper arch will then be stabilized using a 19×25-in stainless steel (SS) arch wire for 2 months. This stage will require approximately 6 months of treatment.

06

What researchers measure

Primary outcomes

  1. Changes in the sagittal pharyngeal airway space (SPAD)

    Time frame: 6 months

Secondary outcomes

  1. Changes in the mandibular position

    Time frame: 6 months

  2. Sagittal skeletal measurements

    Time frame: 6 months

  3. Vertical skeletal measurements

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Jan 2025, 7 months after the start.

Of 88 non-industry interventional studies with no phase under Malocclusion, Angle Class II, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 22. This study's planned 7 months is below that.

Counting every sponsor, half of 88 studies reached it within 15 months; a quarter within 11 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2024
First posted
Sep 19, 2024
StartActual
Jun 20, 2024
Primary completionEst.
Jan 2025
CompletionEst.
Jan 2025
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06602518
Lead sponsor
Nourhan M.Aly
Responsible party
Nourhan M.Aly (Assistant Lecturer of Dental Public Health, University of Alexandria) — Sponsor-investigator
First posted
Sep 19, 2024
Start date
Jun 20, 2024
Primary completion
Jan 2025 (estimated)
Completion
Jan 2025 (estimated)
Last update
Sep 19, 2024

Study contacts

Farah Y Eid, PhD
Contact
farahyousry66@gmail.com
+201001495565
Farah Y Eid, PhD
principal investigator · Faculty of Dentistry, Alexandria University, Egypt
Dina Elfouly, PhD
study director · Faculty of Dentistry, Alexandria University, Egypt
Ahmed Madian, PhD
study chair · Faculty of Dentistry, Alexandria University, Egypt

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion